| EPB051 | Understanding unsuccessful direct-acting antiviral hepatitis C treatment among people living with HIV from the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHECH) | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB052 | Acute HCV infection followed by spontaneous clearance impact on telomere shorting | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB053 | A cluster randomized controlled studyofsecondary distribution of HCV self-test to support micro-elimination in Karachi, Pakistan | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB054 | Hepatitis B prevalence and risk factors among adults living with HIV in South Africa | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB055 | Behavioral factors associated with HCV viremia among HIV-positive men who have sex with men | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB056 | Prospective liver fibrosis assessment in hepatitis B-positive individuals with and without HIV-coinfection in Senegal | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB057 | Long-term serologic responses to different combinations of inactivated hepatitis A virus vaccines among people living with HIV | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB058 | Integrating hepatitis services into community based opioid substitution therapy in three South African cities: interim findings on feasibility and HIV and viral hepatitis C prevalence | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| OALBX0105 | Week 48 results of a Phase 3 randomized controlled trial of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) vs dolutegravir + emtricitabine/tenofovir Disoproxil Fumarate (DTG+F/TDF) as initial treatment in HIV/HBV-coinfected adults (ALLIANCE) | Oral abstract session with live Q&A | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB014 | Performance evaluation of the point-of-care m-PIMA HIV-1/2 Viral Load assay in two South African clinics | E-poster | Viral load and CD4 monitoring |